Toluene

Toluene

SCHEMBL1487693

CC(C)=O.CCCCCC.CCO.Cc1ccccc1

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MMP1MMP13MMP7MMP8polrplArplBrplCrplDrplErplFrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmFrpmGrpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Toluene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 3/20 0.47
CES1 P23141 3/20 0.47
TSHR P16473 2/20 0.46
LMNA P02545 1/20 0.46
ALOX12 P18054 1/20 0.46
ACHE P22303 1/20 0.46
NAAA Q02083 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
TP53 P04637 1/20 0.43
CYP3A4 P08684 1/20 0.43
MAPK1 P28482 1/20 0.43
PTGS2 P35354 1/20 0.42
MEN1 O00255 1/20 0.42
NPC1 O15118 1/20 0.42
RAB9A P51151 1/20 0.42
KMT2A Q03164 1/20 0.42
PCSK9 Q8NBP7 1/20 0.42
EPHX1 P07099 3/20 0.42
EPHX2 P34913 1/20 0.42
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Toluene SCHEMBL2357321 0.96 CES2 (0.50) CES2CES1TSHRLMNAALOX12
Toluene SCHEMBL8853666 0.94 CES2 (0.48) CES2CES1TSHRLMNAALOX12
Heptane SCHEMBL2077664 0.94 CES2 (0.52) CES2CES1TSHRLMNAALOX12
Toluene SCHEMBL1201404 0.91 CES2 (0.50) CES2CES1TSHRLMNAALOX12
Toluene SCHEMBL20568019 0.91 LMNA (0.55) CES2CES1TSHRLMNAALOX12
Toluene SCHEMBL9396513 0.91 LMNA (0.55) CES2CES1TSHRLMNAALOX12
1-Hexanol SCHEMBL28875247 0.90 LMNA (0.48) CES2CES1TSHRLMNANAAA
Toluene SCHEMBL28481131 0.89 LMNA (0.52) CES2CES1TSHRLMNAALOX12
Toluene SCHEMBL8981699 0.89 LMNA (0.52) CES2CES1TSHRLMNAALOX12
Toluene SCHEMBL27586340 0.89 CES2 (0.50) CES2CES1LMNAMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102253161-B Method for detecting content of beta-cryptoxanthin in persistent calyx of physalis QINHUANGDAO DAHUI BIOLOG TECHNOLOGY CO LTD 2013-04-17 CN claimed
CN-102253161-A Method for detecting content of beta-cryptoxanthin in persistent calyx of physalis QINHUANGDAO DAHUI BIOLOG TECHNOLOGY CO LTD 2011-11-23 CN claimed
WO-2023276155-A1 GINGER PROCESSED PRODUCT PRODUCTION METHOD AND GINGER PROCESSED PRODUCT KRAFT株式会社 2023-01-05 WO disclosed
CN-108668557-B Method for enriching lutein by using germinated corn, product and application thereof 江苏省农业科学院 2021-01-19 CN disclosed
US-20200390052-A1 CHINESE LANTERN CLONAL LINE KI1496 BANK OF AMERICA, N.A., AS ADMINISTRATIVE AGENT 2020-12-17 US disclosed
CN-106614754-B Insect excrement extract, preparation method thereof and application thereof in plants 瑞麦德兴(北京)生物科技有限公司 2020-03-27 CN disclosed
CN-108668557-A It is a kind of to utilize method of germination corn enrichment lutein and products thereof and application 江苏省农业科学院 2018-10-19 CN disclosed
US-20170325481-A1 METHOD OF FORMING ENCAPSULATED COMPOSITIONS WITH ENHANCED SOLUBILITY AND STABILITY KEMIN IND INC (US) 2017-11-16 US disclosed
US-9717265-B2 Rumen-protected lutein product for producing high-lutein dairy products KEMIN INDUSTRIES, INC. (US) 2017-08-01 US disclosed
US-20170143646-A1 EFFECT OF LIPOPHILIC NUTRIENTS ON DIABETIC EYE DISEASES OMNIACTIVE HEALTH TECHNOLOGIES LIMITED (IN) 2017-05-25 US disclosed
CN-106614754-A Fecula extract, preparation method thereof, and application of fecula extract to plants 善土(北京)生物科技有限公司 2017-05-10 CN disclosed
US-20090090168-A1 Embedded Piezoelectric Microcantilever Sensors NATIONAL SCIENCE FOUNDATION 2009-04-09 US disclosed
US-7395693-B2 Embedded piezoelectric microcantilever sensors The Arizona Board of Regents, a body corporate of the state of Arizona acting for Northern Arizona University (US) 2008-07-08 US disclosed
WO-2008080152-A2 CAROTENOID-BASED PIGMENTER KEMIN INDUSTRIES, INC. (US) 2008-07-03 WO disclosed
US-20070119236-A1 Embedded piezoelectric microcantilever sensors NATIONAL SCIENCE FOUNDATION 2007-05-31 US disclosed
US-7223909-B2 Genome contains a transgene that encodes a chimeric ketolase enzyme polypeptide having two portions, an N-terminal portion containing plastid transit peptide portion fused to a second ketolase enzyme portion BALL HORTICULTURAL (US) 2007-05-29 US disclosed
US-20060171995-A1 Formulation for increasing the deposition of dietary carotenoids in eggs BANK OF AMERICA, N.A., AS COLLATERAL AGENT 2006-08-03 US disclosed
US-6844020-B2 Solutions of carotenoids for use in foods and personal care products KEMIN FOODS, L.C. (US) 2005-01-18 US disclosed
US-20040018279-A1 Solutions of carotenoids for use in foods and personal care products BANK OF AMERICA, N.A., AS COLLATERAL AGENT 2004-01-29 US disclosed
US-20040003430-A1 Genome contains a transgene that encodes a chimeric ketolase enzyme polypeptide having two portions, an N-terminal portion containing plastid transit peptide portion fused to a second ketolase enzyme portion BALL HORTICULTURAL 2004-01-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040003430-A1 Genome contains a transgene that encodes a chimeric ketolase enzyme polypeptide having two portions, an N-terminal portion containing plastid transit peptide portion fused to a second ketolase enzyme portion CYP11A1, COASY, CPN1 CES2 500/4885CES1 40/4885TSHR 2098/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.